key: cord-0875976-la7vfb9c authors: Mehra, Reena; Tjurmina, Olga A.; Ajijola, Olujimi A.; Arora, Rishi; Bolser, Donald C.; Chapleau, Mark W.; Chen, Peng-Sheng; Clancy, Colleen E.; Delisle, Brian P.; Gold, Michael R.; Goldberger, Jeffrey J.; Goldstein, David S.; Habecker, Beth A.; Handoko, M. Louis; Harvey, Robert; Hummel, James P.; Hund, Thomas; Meyer, Christian; Redline, Susan; Ripplinger, Crystal M.; Simon, Marc A.; Somers, Virend K.; Stavrakis, Stavros; Taylor-Clark, Thomas; Undem, Bradley Joel; Verrier, Richard L.; Zucker, Irving H.; Sopko, George; Shivkumar, Kalyanam title: Research Opportunities in Autonomic Neural Mechanisms of Cardiopulmonary Regulation: A Report From the National Heart, Lung, and Blood Institute and the National Institutes of Health Office of the Director Workshop date: 2022-01-26 journal: JACC Basic Transl Sci DOI: 10.1016/j.jacbts.2021.11.003 sha: d7c382483d481820bb7734f4649dceec2d83c707 doc_id: 875976 cord_uid: la7vfb9c This virtual workshop was convened by the National Heart, Lung, and Blood Institute, in partnership with the Office of Strategic Coordination of the Office of the National Institutes of Health Director, and held September 2 to 3, 2020. The intent was to assemble a multidisciplinary group of experts in basic, translational, and clinical research in neuroscience and cardiopulmonary disorders to identify knowledge gaps, guide future research efforts, and foster multidisciplinary collaborations pertaining to autonomic neural mechanisms of cardiopulmonary regulation. The group critically evaluated the current state of knowledge of the roles that the autonomic nervous system plays in regulation of cardiopulmonary function in health and in pathophysiology of arrhythmias, heart failure, sleep and circadian dysfunction, and breathing disorders. Opportunities to leverage the Common Fund’s SPARC (Stimulating Peripheral Activity to Relieve Conditions) program were characterized as related to nonpharmacologic neuromodulation and device-based therapies. Common themes discussed include knowledge gaps, research priorities, and approaches to develop novel predictive markers of autonomic dysfunction. Approaches to precisely target neural pathophysiological mechanisms to herald new therapies for arrhythmias, heart failure, sleep and circadian rhythm physiology, and breathing disorders were also detailed. This virtual workshop was convened by the National Heart, Lung, and Blood Institute, in partnership with the Office of Strategic Coordination of the Office of the National Institutes of Health Director, and held September 2 to 3, 2020. The intent was to assemble a multidisciplinary group of experts in basic, translational, and clinical research in neuroscience and cardiopulmonary disorders to identify knowledge gaps, guide future research efforts, and foster multidisciplinary collaborations pertaining to autonomic neural mechanisms of cardiopulmonary regulation. The group critically evaluated the current state of knowledge of the roles that the autonomic nervous system plays in regulation of cardiopulmonary function in health and in pathophysiology of arrhythmias, heart failure, sleep and circadian dysfunction, and breathing disorders. Opportunities to leverage the Common Fund's SPARC (Stimulating Peripheral Activity to Relieve Conditions) program were characterized as related to nonpharmacologic neuromodulation and device-based therapies. Common themes discussed include knowledge gaps, research priorities, and approaches to develop novel predictive markers of autonomic dysfunction. Approaches to precisely target neural pathophysiological mechanisms to herald new therapies for arrhythmias, heart failure, sleep and circadian rhythm physiology, and breathing disorders were also detailed. however, they are invasive, expensive, and also associated with side effects (2) . Furthermore, there are limitations with human model systems including heart rate, heart rate variability (HRV), plasma catecholamines, and noradrenaline spillover that can have limitations in terms of largescale implementation, can be confounded in certain states such as heart failure (HF), and have age-and sex-specific influences that need to be considered (3) . The overarching conceptual framework of opportunities presented in this report is characterized by a better The premise of the workshop is based upon a need to articulate gaps and research priorities specific to the ANS-responsible for regulation of cardiac, vascular, and pulmonary physiology via maintaining a balance of sympathetic and parasympathetic outputs to the heart, vasculature, and lungs in response to stimuli. The ANS plays a key role in the development and progression of cardiopulmonary disease and in sleep and circadian rhythm pathophysiology. Aff ¼ afferent; ANS ¼ autonomic nervous system; DRG ¼ dorsal root ganglia; HR ¼ heart rate; ParaSNA ¼ parasympathetic nerve activity; SNA ¼ sympathetic nerve activity. gaps and opportunities to accelerate key discoveries in neural science and neurotherapeutics in cardiopulmonary and sleep and circadian rhythm disorders. Importantly, targeting the ANS is a major therapeutic opportunity, and therefore, key to this is understanding the neurobiology of end-organ function in normal and disease states. This report presents a summary of cross-cutting themes, challenges, opportunities, and available resources discussed at the workshop. function. Sensory afferent fibers innervating the heart, vasculature, and lungs include mechanosensitive nerves that detect changes in cardiac stretch, lung stretch, blood pressure, and blood volume, and chemosensitive fibers that are normally quiescent, but are activated by stimuli such as ischemia and inflammation (7) . Information transmitted to the brainstem (8, 9) Normal cardiopulmonary reflexes are disrupted in disease, leading to increased sympathetic and decreased parasympathetic transmission. Injury activates afferent nerves that mediate sympathoexcitatory-positive feedback reflexes that contribute to myocardial and/or lung injury. We do not adequately understand (clockwise from top) the electrophysiological and biophysical properties of autonomic ganglia; the impact of sex as a biological variable; how to distinguish the roles of ganglionic versus systemic inflammation in neural remodeling; the mechanisms that drive afferent and efferent remodeling during disease; how to integrate clinical data from a variety of sources, scales, and modalities to guide therapy for specific patients; and the nature of interactions between cardiac and pulmonary nerves. neuropeptides. Release of norepinephrine (NE) has positive chronotropic, dromotropic, and inotropic effects (11) , but sympathetic activation has a limited effect on airway smooth muscle or mucus secretion (although circulating epinephrine causes bronchodilation). Parasympathetic transmission predominates in healthy humans, and decreased cardiac parasympathetic tone or the ratio of sympathetic to parasympathetic tone are powerful predictors of susceptibility to arrhythmia and death. Normal cardiopulmonary reflexes are disrupted in disease states, for example, ischemia, hypertension, and chronic HF, leading to increased sympathetic and decreased parasympathetic transmission ( Figure 1 ). In some instances, ischemia or mechanical changes activate afferents that mediate sympathoexcitatory, positive feedback reflexes in a nonhomeostatic way (12, 13) . Excessive sympathetic transmission contributes to cardiac hypertrophy and fibrosis, and can trigger arrhythmias (14) . This pathologic increase in sympathetic outflow can be blunted by selective destruction of cardiac spinal afferents using resiniferatoxin (14, 15 (27, 28) . The coordination of NE synthesis, release, and removal becomes disrupted, with elevated release and suppressed reuptake leading to high extracellular NE that is detrimental to the heart (29) . As the disease progresses, acetylcholine (Ach) replaces NE in some sympathetic neurons, and NPY synthesis and release increase, potentially contributing to pathology (30, 31) . It is now recognized that neural remodeling occurs throughout the nervous system in HF. In addition to neurochemical plasticity, morphologic changes include remodeling of axon arbors in the heart-both degeneration and regrowthas well as increased size of cell bodies and dendritic arbors within stellate and intracardiac ganglia (27, 28) . Electrical remodeling includes enhanced excitability in stellate ganglia (32) , altered firing frequencies of sensory afferents (33) and parasympathetic efferents, as well as remodeling of connections within intracardiac ganglia (34) . These neural changes influence the heart, causing down-regulation of b1, upregulation of b2 adrenergic receptors, and modulating cardiac electrophysiology (35) . A recent clinical trial showed that propranolol, which blocks both b1 and b2 receptors, is much more effective than metoprolol in managing patients with electrical storm (36) . adapted from Goldstein (201) shows a concept diagram relating stress to chronic disorders such as heart failure that involve autonomic effectors. Stress is a condition in which a homeostatic comparator senses a discrepancy between afferent information to the brain about a monitored variable and a set point or other instructions for responding. The error signal drives effectors including components of the autonomic nervous system in a manner that reduces the discrepancy. Cumulative wear and tear (allostatic load) decreases effector efficiency, eventually precipitating dyshomeostatic vicious cycles. Feed-forward anticipatory processes shift input-output curves determined by the "Regulator." The right panel shows major types of sensory afferent nerves and the corresponding abnormalities in autonomic reflexes observed in heart failure are illustrated. Sympathoexcitatory afferents are shown in green; sympathoinhibitory afferents in blue. Examples of underlying mechanisms acting at sensory, central, efferent, and effector organ sites that contribute to the reflex cardiovascular/respiratory dysregulation are noted. Aff ¼ afferent; DRG ¼ dorsal root ganglia; HR ¼ heart rate; ParaSNA ¼ parasympathetic nerve activity; SNA ¼ sympathetic nerve activity. Other sleep disturbances also can trigger the ANS and contribute to CVD. Periodic limb movements can trigger large sympathetic and blood pressure surges, and in the long term, are associated with increased risk for daytime hypertension and CVD (172, 173) . Insomnia and other disorders characterized by sleep fragmentation also lead to SNSA and are associated with CVD (174) . However, the roles of treating these disorders as a strategy for CVD risk reduction or for treating associated AD have not been systematically assessed. A summary of the ANS alterations association with sleep and circadian processes and the related knowledge gaps and research priorities are depicted in Figure 5 . Airway hyper-responsiveness is a hallmark of asthma (and some forms of chronic obstructive pulmonary disease [COPD] ) that is defined as increased sensitivity to bronchospastic agents ( Figure 6 ). Figure 6 ). Consequences include perturbations of resting cardiac physiology (increased heart rate, loss of HRV, increased nocturnal blood pressure) as well as exercise physiology (diminished maximal heart rate, slower heart rate increase and recovery, decreased contractility, decreased functional capacity) (188) . Over the course of years after transplantation, there can be a process of reinnervation (which may improve functional capacity and outcomes) (189, 190) , but this is highly variable and not well-understood. Pulmonary parasympathetic activity is enhanced in COPD and may play a critical role in the airway obstruction, airway hyper-responsiveness, and increased mucus production characteristic of this condition (184, 191) . Inhaled anticholinergic therapies have thus been the mainstay of COPD treatment (192, 193) . Similarly, disruption of pulmonary parasympathetic nerves in patients with COPD has the potential to provide long-lasting anticholinergic effects with reduction of symptoms and exacerbations. Targeted lung denervation (TLD) is a novel bronchoscopic therapy that disrupts the afferent and efferent pulmonary branches of the vagus nerve along the outside of the main stem bronchi using radiofrequency ablation ( Figure 6 ). Initial studies have demonstrated the safety and feasibility of TLD and have shown trends toward improvements in symptoms and exacerbations (194, 195) ; its efficacy is currently being assessed in the pivotal AIRFLOW-3 (Evaluation of the Safety and Efficacy of TLD in Patients With COPD) trial (196) . Determining the appropriate radiofrequency ablation parameters in TLD is challenging because there are few direct assessments of afferent/efferent function. Because TLD also targets lung afferents, evaluation of cardiopulmonary reflexes such as respiratory sinus arrhythmia pre-and post-treatment may have the potential to assess the extent of pulmonary vagal denervation achieved with this approach (197, 198) . 1. There are critical gaps in our understanding of the contribution of specific afferent and efferent nerve subsets (199, 200) Autonomic modulation for cardiovascular disease Effects of transcutaneous auricular vagus nerve stimulation on cardiovascular autonomic control in health and disease Preclinical and clinical evaluation of autonomic function in humans The autonomic nervous system and cardiac arrhythmias: current concepts and emerging therapies Clinical neurocardiology defining the value of neuroscience-based cardiovascular therapeutics Molecular and cellular neurocardiology: development, and cellular and molecular adaptations to heart disease An atlas of vagal sensory neurons and their molecular specialization Mapping of sensory nerve subsets within the vagal ganglia and the brainstem using reporter mice for Pirt, TRPV1, 5-HT3, and Tac1 expression Modeling beta-adrenergic control of cardiac myocyte contractility in silico Mechanisms of cardiac pain Intrapericardial capsaicin and bradykinin induce different cardiacsomatic and cardiovascular reflexes in rats Cardiac TRPV1 afferent signaling promotes arrhythmogenic ventricular remodeling after myocardial infarction Cardiac sympathetic afferent denervation attenuates cardiac remodeling and improves cardiovascular dysfunction in rats with heart failure Innervation and neuronal control of the mammalian sinoatrial node a comprehensive atlas Characterization of cardiovascular reflexes evoked by airway stimulation with allylisothiocyanate Nociceptive pulmonary-cardiac reflexes are altered in the spontaneously hypertensive rat Cardiac ganglionitis associated with sudden unexpected death Inflammation, oxidative stress, and glial cell activation characterize stellate ganglia from humans with electrical storm The effects of interleukin 17A on left stellate ganglion remodeling are mediated by neuroimmune communication in normal structural hearts Neuro-immune crosstalk and allergic inflammation Cardiac exosomes in ischemic heart disease-a narrative review. Diagnostics (Basel) Insights into the proteomic profiling of extracellular vesicles for the identification of early biomarkers of neurodegeneration Cardiac noradrenergic nerve terminal abnormalities in dogs with experimental congestive heart failure Relationship between regional cardiac hyperinnervation and ventricular arrhythmia Nerve sprouting and sudden cardiac death Cardiac sympathetic nerve function in congestive heart failure Heart failure causes cholinergic transdifferentiation of cardiac sympathetic nerves via gp130-signaling cytokines in rodents Coronary sinus neuropeptide Y levels and adverse outcomes in patients with stable chronic heart failure Electroanatomic remodeling of the left stellate ganglion after myocardial infarction Cardiac sympathetic afferent reflex control of cardiac function in normal and chronic heart failure states Cardiac sympathetic denervation for refractory ventricular arrhythmias Beta 1-and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure Propranolol versus metoprolol for treatment of electrical storm in patients with implantable cardioverter-defibrillator Neurotransmitter switching coupled to betaadrenergic signaling in sympathetic neurons in prehypertensive states Cardiopulmonary baroreflex control of renal sympathetic nerve activity is impaired in dogs with left ventricular dysfunction Sympathetic activation in congestive heart failure: an updated overview Influence of brain-derived neurotrophic factortyrosine receptor kinase B signalling in the nucleus tractus solitarius on baroreflex sensitivity in rats with chronic heart failure Altered ENaC is associated with aortic baroreceptor dysfunction in chronic heart failure Cellular and molecular mechanisms underlying arterial baroreceptor remodeling in cardiovascular diseases and diabetes Inhibition of chemoreceptor inputs to nucleus of tractus solitarius neurons during baroreceptor stimulation 0 2 2 sympathetic afferents inhibits baroreflex in rats with heart failure Human carotid bodies as a therapeutic target: new insights from a clinician's perspective Altered arterial baroreflexmuscle metaboreflex interaction in heart failure Sympathetic and baroreflex alterations in congestive heart failure with preserved, midrange and reduced ejection fraction Nitrosative stress drives heart failure with preserved ejection fraction Female sex is protective in a preclinical model of heart failure with preserved ejection fraction Nicotinamide for the treatment of heart failure with preserved ejection fraction Striking volume intolerance is induced by mimicking arterial baroreflex failure in normal left ventricular function Baroreflex sensitivity impairment is associated with cardiac diastolic dysfunction in rats Splanchnic nerve block for chronic heart failure The ion channel ASIC2 is required for baroreceptor and autonomic control of the circulation PIEZOs mediate neuronal sensing of blood pressure and the baroreceptor reflex Arterial baroreceptors sense blood pressure through decorated aortic claws Tentonin 3/ TMEM150C senses blood pressure changes in the aortic arch Astrocytes monitor cerebral perfusion and control systemic circulation to maintain brain blood flow Astrocytes modulate baroreflex sensitivity at the level of the nucleus of the solitary tract Heterogeneous neurochemical responses to different stressors: a test of Selye's doctrine of nonspecificity Adrenaline and the Inner World: An Introduction to Scientific Integrative Medicine How does homeostasis happen? Integrative physiological, systems biological, and evolutionary perspectives Neurohumoral features of myocardial stunning due to sudden emotional stress Vagal nerve stimulation markedly improves long-term survival after chronic heart failure in rats Chronic vagus nerve stimulation: a new and promising therapeutic approach for chronic heart failure Spinal cord stimulation improves ventricular function and reduces ventricular arrhythmias in a canine postinfarction heart failure model Spinal cord stimulation is safe and feasible in patients with advanced heart failure: early clinical experience Thoracic Spinal Cord Stimulation for HEArt Failure as a Restorative Treatment (SCS HEART study): firstin-man experience Chronic baroreceptor activation enhances survival in dogs with pacing-induced heart failure. Hypertension Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction Baroreflex activation therapy in patients with heart failure with reduced ejection fraction Determining the Feasibility of Spinal Cord Neuromodulation for the Treatment of Chronic Systolic Heart Failure: the DEFEAT-HF study Vagus nerve stimulation for the treatment of heart failure: the INOVATE-HF trial Betablocker therapy for long QT syndrome and catecholaminergic polymorphic ventricular tachycardia: are all beta-blockers equivalent? Heart Rhythm Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society Role of the autonomic nervous system in atrial fibrillation: pathophysiology and therapy The role of the autonomic ganglia in atrial fibrillation Low-level transcutaneous electrical vagus nerve stimulation suppresses atrial fibrillation Transcutaneous Electrical Vagus Nerve Stimulation to Suppress Atrial Fibrillation): a randomized clinical trial Neuromodulation for the treatment of heart rhythm disorders The role of the autonomic nervous system in cardiac arrhythmias: the neuro-cardiac axis, more foe than friend? Ganglion plexus ablation in advanced atrial fibrillation: the AFACT study Calcium-induced autonomic denervation in patients with postoperative atrial fibrillation Selective atrial vagal denervation guided by evoked vagal reflex to treat patients with paroxysmal atrial fibrillation Central sympathetic inhibition to reduce ear: fMRI evidence in humans Vagus nerve stimulation inhibits cytokine production and attenuates disease severity in rheumatoid arthritis Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation Association of atrial fibrillation and obstructive sleep apnea Obstructive sleep apnea and the recurrence of atrial fibrillation Central sleep apnea in atrial fibrillation: risk factor or marker of untreated underlying disease? Association of nocturnal arrhythmias with sleepdisordered breathing: the Sleep Heart Health Study Nocturnal arrhythmias across a spectrum of obstructive and central sleep-disordered breathing in older men: outcomes of sleep disorders in older men (MrOS sleep) study Triggering of nocturnal arrhythmias by sleepdisordered breathing events The role of ganglionated plexi in apnea-related atrial fibrillation Effect of renal denervation on neurohumoral activation triggering atrial fibrillation in obstructive sleep apnea. Hypertension Low-level but not high-level baroreceptor stimulation inhibits atrial fibrillation in a pig model of sleep apnea Atrial fibrillation in acute obstructive sleep apnea: autonomic nervous mechanism and modulation Effect of obstructive sleep apnea and its treatment of atrial fibrillation recurrence after radiofrequency catheter ablation: a meta-analysis Shift in the pattern of autonomic atrial innervation in subjects with persistent atrial fibrillation Targeted nonviral gene-based inhibition of Galpha(i/o)-mediated vagal signaling in the posterior left atrium decreases vagal-induced atrial fibrillation Targeted G-protein inhibition as a novel approach to decrease vagal atrial fibrillation by selective parasympathetic attenuation Cardiac glial cells release neurotrophic S100B upon catheter-based treatment of atrial fibrillation Alteration of parasympathetic/sympathetic heart: a novel antiarrhythmic therapy. Circulation Augmentation of left ventricular contractility by cardiac sympathetic neural stimulation Efferent sympathetic and vagal innervation of the canine right ventricle Disruption of cardiac cholinergic neurons enhances susceptibility to ventricular arrhythmias The cardiac sympathetic co-transmitter neuropeptide Y is proarrhythmic following ST-elevation myocardial infarction despite beta-blockade Cardiac sympathetic nerve transdifferentiation reduces action potential heterogeneity after myocardial infarction Sympathetic neural recording-it is all in the details Simultaneous noninvasive recording of skin sympathetic nerve activity and electrocardiogram Simultaneous noninvasive recording of electrocardiogram and skin sympathetic nerve activity (neuECG) Atrial fibrillation and ventricular arrhythmias: sex differences in electrophysiology, epidemiology, clinical presentation, and clinical outcomes Incidence of atrial fibrillation in whites and African-Americans: the Atherosclerosis Risk in Communities (ARIC) study Age, race, and sex differences in autonomic cardiac function measured by spectral analysis of heart rate variability-the ARIC study. Atherosclerosis Risk in Communities J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge Circadian variation in the incidence of sudden cardiac death in the Framingham Heart Study population Prospective evidence of a circadian rhythm for out-of-hospital cardiac arrests Temporal differences in out-of-hospital cardiac arrest incidence and survival Reduction in inappropriate ICD therapy in MADIT-RIT patients without history of atrial tachyarrhythmia Circadian variability in the occurrence of sudden cardiac death in patients with hypertrophic cardiomyopathy The circadian pattern of the development of ventricular fibrillation in patients with Brugada syndrome Circadian variation of ventricular arrhythmias in catecholaminergic polymorphic ventricular tachycardia An international, multicentered, evidence-based reappraisal of genes reported to cause congenital long QT syndrome Seasonal and circadian distributions of cardiac events in genotyped patients with congenital long QT syndrome Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for lifethreatening arrhythmias Role of the circadian system in cardiovascular disease Circadian variation and triggers of onset of acute cardiovascular disease Role of the autonomic nervous system in modulating cardiac arrhythmias Ventricular tachycardia in ischemic heart disease: the sympathetic heart and its scars Cardiac sympathetic denervation in patients with refractory ventricular arrhythmias or electrical storm: intermediate and long-term follow-up Wireless and battery-free technologies for neuroengineering Circadian rhythm of cardiac electrophysiology, arrhythmogenesis, and the underlying mechanisms Circadian variation in human ventricular refractoriness Circadian variation of heart rate variability Circadian rhythm: potential therapeutic target for atherosclerosis and thrombosis Circadian rhythms and cardiovascular health Diurnal heart rate patterns in inappropriate sinus tachycardia Blood pressure non-dipping and obstructive sleep apnea syndrome: a metaanalysis Circadian mechanisms: cardiac ion channel remodeling and arrhythmias Circadian rhythms of cardiovascular autonomic function: Physiology and clinical implications in neurodegenerative diseases Sleep, circadian rhythms and health Heart-rate variability and cardiac autonomic function in diabetes Circadian and gender effects on repolarization in healthy adults: a study using harmonic regression analysis Association of sleep characteristics with cardiovascular and metabolic risk factors in a population sample: the Chicago Area Sleep study Disruption of the circadian clock within the cardiomyocyte influences myocardial contractile function, metabolism, and gene expression A circadian clock in the sinus node mediates daynight rhythms in Hcn4 and heart rate The cardiomyocyte molecular clock regulates the circadian expression of Kcnh2 and contributes to ventricular repolarization Clock genes alterations and endocrine disorders Deficient of a clock gene, brain and muscle Arnt-like protein-1 (BMAL1), induces dyslipidemia and ectopic fat formation Role of mutation of the circadian clock gene Per2 in cardiovascular circadian rhythms Cardiovascular physiology and coupling with respiration: central and autonomic regulation Impact of sleep on arrhythmogenesis Sympathetic-nerve activity during sleep in normal subjects Sleep, dreams, and sudden death: the case for sleep as an autonomic stress test for the heart Sleep apnea: types, mechanisms, and clinical cardiovascular consequences Regulation of breathing and autonomic outflows by chemoreceptors Effect of autonomic blocking agents on the respiratory-related oscillations of ventricular action potential duration in humans O2 sensing, mitochondria and ROS signaling: the fog is lifting Hypoxia and aging Obstructive sleep apnoea and hypertension: the role of the central nervous system Obstructive sleep apnea and systemic hypertension: gut dysbiosis as the mediator? Hypoglossal nerve stimulation and heart rate variability: analysis of STAR trial responders Sex differences in obstructive sleep apnea phenotypes, the Multi-Ethnic Study of Atherosclerosis More than the sum of the respiratory events: personalized medicine approaches for obstructive sleep apnea The sleep apnea-specific pulse rate response predicts cardiovascular morbidity and mortality Osteoporotic Fractures in Men (MrOS) Study Group. Individual periodic limb movements with arousal are temporally associated with nonsustained ventricular tachycardia: a case-crossover analysis Associations of incident cardiovascular events with restless legs syndrome and periodic leg movements of sleep in older men, for the outcomes of sleep disorders in older men study (mros sleep study) Insomnia and risk of cardiovascular disease Vonk-Noordegraaf A. Neurohormonal axis in patients with pulmonary arterial hypertension: friend or foe? Right ventricular diastolic impairment in patients with pulmonary arterial hypertension Bisoprolol in idiopathic pulmonary arterial hypertension: an explorative study Contribution of impaired parasympathetic activity to right ventricular dysfunction and pulmonary vascular remodeling in pulmonary arterial hypertension Effect of inhaled corticosteroids on bronchial responsiveness in patients with "corticosteroid naive" mild asthma: a meta-analysis Persistent airway inflammation and bronchial hyperwith uncontrolled asthma Lung eosinophils increase vagus nerve-mediated airway reflex bronchoconstriction in mice Reflex regulation of airway smooth muscle tone Autonomic neural control of intrathoracic airways Vagotomy reverses established allergen-induced airway hyperreactivity to methacholine in the mouse Population of sensory neurons essential for asthmatic hyperreactivity of inflamed airways Early denervation and later reinnervation of the heart following cardiac transplantation: a review Normalization of the heart rate response to exercise 6 months after cardiac transplantation Reinnervation post-heart transplantation Cholinergic and neurogenic mechanisms in obstructive airways disease Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a oncedaily inhaled anticholinergic bronchodilator: a randomized trial Tiotropium versus salmeterol for the prevention of exacerbations of COPD Safety and Adverse Events after Targeted Lung Denervation for Symptomatic Moderate to Severe Chronic Obstructive Pulmonary Disease (AIRFLOW). A multicenter randomized controlled clinical trial Two-year outcomes for the double-blind, randomized, sham-controlled study of targeted lung denervation in patients with moderate to severe COPD: AIRFLOW-2 Design for a multicenter, randomized, sham-controlled study to evaluate Physiologic and histopathologic effects of targeted lung denervation in an animal model Respiratory sinus arrhythmia attenuation via targeted lung denervation in sheep and humans Vagal afferent innervation of the airways in health and disease Molecular identity, anatomy, gene expression and function of neural crest vs. placode-derived nociceptors in the lower airways Concepts of scientific integrative medicine applied to the physiology and pathophysiology of catecholamine systems Autonomic nervous system dysfunction: JACC focus seminar